Table 3.
Continent | Studies | N 1 | Prevalence (%) | Range (%) | Heterogeneity | Refs | ||
---|---|---|---|---|---|---|---|---|
Mean | CI 95% 2 | Min | Max | I2 3 (p Value) | ||||
Africa | 1 | 13 | 7.69 | 1.37–33.31 | 7.69 | 7.69 | N/A 4 | [21] |
Asia | 8 | 197 | 65.99 | 59.12–72.24 | 21.43 | 100.00 | 95.58 (<0.001) | 5 |
Europe | 35 | 4590 | 44.38 | 42.95–45.82 | 0.00 | 100.00 | 99.98 (<0.001) | 6 |
North America | 32 | 1933 | 48.58 | 46.35–50.81 | 0.00 | 100.00 | 95.26 (<0.001) | 7 |
South and Central America | 34 | 2358 | 18.87 | 17.34–20.50 | 0.00 | 100.00 | 83.15 (<0.001) | 8 |
Global | 110 | 9091 | 39.07 | 38.07. 40.08 | 0 | 100 | 99.94 (<0.001) |